EAM
Empirical Asset Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-875
| Closed | -$203K | – | 313 |
|
|
2024
Q2 | $203K | Sell |
875
-150
| -15% | -$34.8K | 0.08% | 306 |
|
|
2024
Q1 | $221K | Sell |
1,025
-290
| -22% | -$62.5K | 0.11% | 250 |
|
|
2023
Q4 | $340K | Buy |
1,315
+106
| +9% | +$27.4K | 0.28% | 124 |
|
|
2023
Q3 | $311K | Hold |
1,209
| – | – | 0.27% | 118 |
|
|
2023
Q2 | $344K | Sell |
1,209
-100
| -8% | -$28.5K | 0.3% | 107 |
|
|
2023
Q1 | $364K | Sell |
1,309
-1,542
| -54% | -$429K | 0.35% | 100 |
|
|
2022
Q4 | $777K | Sell |
2,851
-334
| -10% | -$91K | 0.82% | 35 |
|
|
2022
Q3 | $850K | Buy |
+3,185
| New | +$850K | 0.93% | 28 |
|
|
2022
Q2 | – | Sell |
-3,183
| Closed | -$670K | – | 156 |
|
|
2022
Q1 | $670K | Buy |
3,183
+2,012
| +172% | +$424K | 0.64% | 49 |
|
|
2021
Q4 | $281K | Buy |
+1,171
| New | +$281K | 0.27% | 117 |
|